Bruker Corp (BRKRP) Asset Writedowns and Impairment (2010 - 2026)

Bruker (BRKRP) has 13 years of Asset Writedowns and Impairment data on file, last reported at $4.8 million in Q4 2025.

• Quarterly Asset Writedowns and Impairment rose 380.0% year-over-year to $4.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $26.0 million (up 15.04% YoY) and the FY2025 annual result came in at $152.3 million, up 434.39% from the prior year.
• Asset Writedowns and Impairment advanced to $4.8 million in Q4 2025, from $1.0 million in the prior quarter.
• In the past five years, Asset Writedowns and Impairment ranged from a high of $20.2 million in Q2 2024 to a low of -$1.9 million in Q3 2022.
• A 4-year average of $4.5 million and a median of $2.0 million in 2022 frame the typical range for Asset Writedowns and Impairment.
• Annual changes were most pronounced in 2023 — Asset Writedowns and Impairment surged 11500.0% — and 2024, when it slumped 79.71%.
• Tracing BRKRP's Asset Writedowns and Impairment over 4 years: stood at $1.6 million in 2022, then jumped by 68.75% to $2.7 million in 2023, then plunged by 62.96% to $1.0 million in 2024, then soared by 380.0% to $4.8 million in 2025.
• The last three Asset Writedowns and Impairment figures came in at $4.8 million (Q4 2025), $1.0 million (Q4 2024), and $20.2 million (Q2 2024), per Business Quant data.